{"references": ["Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical Implications. Arch Med Sci. 2015;11(6):1164-1178.", "Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148- 160.", "Wang JX, Rogers LM, Gross EZ, et al. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science (80- ). 2014;345(6200):1054-1057", "Wei CW, Sun Y, Chen N, et al. Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia. Psychoneuroendocrinology. 2020;111:104473.", "Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis. Prog Neurobiol. 2005;76(2):99- 125.", "Schrag M, Mueller C, Zabel M, et al. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis. Neurobiol Dis. 2013;59:100-110.", "Zhao X, Li Y, Tian Q, et al. Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1\u03b2 and tumor necrosis factor-\u03b1 in elderly patients with refractory depression. J Int Med Res. 2019;47(5):1848-1855."]}

This poster has been prepared to be presented in the FENS 2020 Virtual Forum (11-15 July).